MedPath

Long or Very Long-Limb Gastric Bypass in Superobese

Phase 3
Conditions
Obesity
Interventions
Procedure: laparoscopic gastric Roux-en-Y gastric bypass
Registration Number
NCT00868543
Lead Sponsor
Kaunas University of Medicine
Brief Summary

The goal of this study is to compare the clinical efficacy (weight loss and metabolic changes) of long (150 cm) versus very long (250cm) Roux alimentary limb gastric bypass in superobese (BMI\>50) patients.

Detailed Description

The study is a multicentre trial in which superobese (BMI\>50) patients will be randomly assigned (in a 1:1 ratio) for laparoscopic gastric Roux-en-Y gastric bypass with: a) long (150 cm) or b) very long (250cm) alimentary Roux limb. Patients will be included from three hospitals: Kaunas University of Medicine Hospital (Lithuania), Klaipeda District Hospital (Lithuania), Vaasa Central Hospital (Finland) ) where preoperative investigation, the same technique surgical procedures and follow up will be performed acording approved protocol.

Approximate duration of subject participation

Subjects in the study will participate for approximately 5 years:

* Preoperative investigation and surgery 3- 5 days in the hospital;

* First follow up visit: 6 months after surgery;

* Next follow up visits: 12, 24, 36, 48 months after surgery;

* Last follow up visit: 5 years after surgery.

* The interim results after 12, 24 and 36 months will be calculated and presented before end of the study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Hospitalized male or female subjects 18-65 years of age.
  • Obese subjects with body mass index (BMI= kg/m²)>50
  • Patients without mental or nervous disorders interfering with adequate evaluation of one's health condition.
  • Patients who read the informed consent form and gave a written consent to participate in the study.
Read More
Exclusion Criteria
  • Previous open abdominal surgery, except appendectomy, cholecystectomy and gynaecological procedures.
  • Presence of any significance cardiac, hepatic, renal, blood, alimentary tract disease which may lead to system or organ failure in intraoperative or postoperative period.
  • Pregnant women.
  • Subjects taking immunosuppressive therapy.
  • Any concomitant condition that, in the opinion of the investigator, would preclude an operation and postoperative follow up acording to a protocol
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Long limblaparoscopic gastric Roux-en-Y gastric bypassHospitalized male or female subjects 18-65 years of age,obese with body mass index (BMI= kg/m²)\>50.Patients without mental or nervous disorders interfering with adequate evaluation of one's health condition, who read the informed consent form and gave a written consent to participate in the study. Gastric bypass was performed with long (150 cm) alimentary Roux limb
Very long limblaparoscopic gastric Roux-en-Y gastric bypassHospitalized male or female subjects 18-65 years of age,obese with body mass index (BMI= kg/m²)\>50.Patients without mental or nervous disorders interfering with adequate evaluation of one's health condition, who read the informed consent form and gave a written consent to participate in the study. Gastric bypass was performed with very long (250 cm) alimentary Roux limb
Primary Outcome Measures
NameTimeMethod
weight loss- we will compare percentage of excess body weight loss (%EWL) between groups.7 years
Secondary Outcome Measures
NameTimeMethod
To compare body mass index changes and absolute weight loss. To evaluate obesity-related medical problems. To obtain data about impromvement of metabolic syndrom. To compare quality of life changes between treatment arms.7 years

Trial Locations

Locations (1)

KMUK, surgery department

🇱🇹

Kaunas, Lithuania

© Copyright 2025. All Rights Reserved by MedPath